Participants 92 148 7
patients with standard-risk acute lymphoblastic leukemia
Participants 219 263 3
childhood acute lymphoblastic leukemia (ALL)
Participants 525 548 7
more than 1000 subjects
Participants 618 675 6
Children with National Cancer Institute standard-risk ALL
